Management of High Ferritin Levels
Diagnosis and Assessment
- The American Association for the Study of Liver Diseases recommends assessing transferrin saturation (TSAT) to determine iron overload, with TSAT >45-50% suggesting true iron overload 1
- The combination of low TSAT (<20%) with elevated ferritin is characteristic of inflammation, and ferritin is both an iron storage protein and an acute phase reactant, according to the American Journal of Hematology guidelines 2
- Inflammatory response is characterized by TSAT <20% and elevated inflammatory markers, while true iron overload is characterized by TSAT >45% and ferritin consistently >1000 ng/mL 3
Treatment
- The American College of Gastroenterology recommends therapeutic phlebotomy as the first-line treatment for hereditary hemochromatosis, with an initial frequency of weekly removal of 500 mL blood and a target ferritin level of 50-100 μg/L 4
- The American College of Gastroenterology recommends avoiding vitamin C supplements and iron-fortified foods, as they can increase iron absorption, and notes that strict dietary iron restrictions have minimal impact compared to phlebotomy 4
- Oral iron supplementation is strongly recommended as first-line treatment for patients with absolute iron deficiency, as indicated by low ferritin and high transferrin, according to the Clinical Nutrition guidelines 5
- Intravenous iron should be considered as first-line treatment in patients with certain conditions, including clinically active inflammatory bowel disease, previous intolerance to oral iron, hemoglobin below 10 g/dL with severe symptoms, congestive heart failure, or malabsorption disorders, as recommended by the Clinical Nutrition and American Journal of Hematology guidelines 5, 6
Iron Chelation Therapy
- The American Society of Hematology recommends iron chelation therapy for patients with serum ferritin >1000 ng/mL, transfusion need ≥2 units/month for >1 year, or evidence of organ dysfunction 7
- The American Society of Hematology recommends deferoxamine at a dose of 20-40 mg/kg/day for iron chelation therapy 4
Monitoring and Maintenance
- Target parameters for patients undergoing phlebotomy include:
| Parameter | Target |
|---|---|
| TSAT | ≥ 20% |
| Ferritin | ≥ 100 ng/mL |
| Hemoglobin | 11.0-12.0 g/dL |
| sTfR/log ferritin ratio | < 1.5 |
- Hemoglobin should be checked after 4 weeks of treatment to assess response, with an expected increase of 1-2 g/dL per month, as recommended by the Journal of the National Comprehensive Cancer Network 10
- Serum ferritin should be monitored to prevent iron overload toxicity, with levels not exceeding 500 μg/L, especially in children and adolescents 11
- Check ferritin and TSAT every 3 months initially, with more frequent monitoring as ferritin approaches normal range, and monitor hemoglobin and hematocrit before each phlebotomy, as recommended by the American Society of Hematology 3
Lifestyle and Dietary Modifications
- Limit iron-rich foods and iron-fortified products, avoid vitamin C supplements >200 mg/day with meals, and maintain a healthy diet without excessive iron intake, as suggested by the National Institute of Diabetes and Digestive and Kidney Diseases 3
- Patients with confirmed iron overload should avoid iron supplementation and iron-fortified foods, limit red meat consumption, avoid vitamin C supplements, and restrict alcohol intake during iron depletion phase, as recommended by the European Association for the Study of the Liver 1
- Addressing alcohol consumption is essential, and complete abstinence is recommended, along with nutritional support and B-vitamin supplementation, as suggested by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) guidelines 12
Follow-up and Disease Management
- Regular CBC monitoring (every 1-2 months initially) and liver function tests every 3 months are necessary for follow-up, as recommended by the American College of Gastroenterology (ACG) guidelines 12
- Reassessing ferritin and transferrin saturation in 3 months can help monitor disease progression, according to the American Gastroenterological Association (AGA) guidelines 1
- Treating underlying liver disease, such as following non-alcoholic fatty liver disease (NAFLD) guidelines, and weight loss through dietary modification and increased physical activity, can help improve outcomes, according to the American Association for the Study of Liver Diseases (AASLD) guidelines 1